Clinical Trial Update: Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update comparing IV fosfomycin (ZTI-01) to piperacillin/tazobactam for complicated urinary tract infections and acute pyelonephritis; completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection
• Pyelonephritis
• Urinary Tract Infection

Drugs mentioned

• Piperacillin/tazobactam (Piperacillin/tazobactam)
• ZTI-01

Snippet

Sponsor: Nabriva Therapeutics AG | Conditions: Urinary Tract Infection Symptomatic, Acute Pyelonephritis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2018-12-11